Mr. Michael Martinz reports

KANEH BOSM EXPANDS CULTIVATION INTO EUROPE WITH GREECE ACQUISITION

Kaneh Bosm Biotechnology Inc. has entered into a definitive agreement with EU Cannabis Corp. to acquire 100 per cent of EU Cannabis's issued and outstanding shares.

EU Cannabis has an option to acquire a 90-per-cent working interest in industrial hemp licences held by Cannatec Greece A.E. Cannatech currently holds three licences covering a total of 16 acres situated within the Greek prefecture of Imathia. These licences were granted to Cannatec by the Hellenic Republic Ministry of Agricultural Development and Food, and permit EU Cannabis to cultivate, manufacture, distribute and export industrial hemp and its many cannabidiol (CBD) derived extracts. Greece boasts over 300 days of unadulterated sunshine per year, resulting in attractive climate for outdoor industrial hemp cultivation.

Eugene Beukman, chief executive officer of Kaneh Bosm, states: "EU Cannabis is equipped with considerable regional and industry experience within the Southern European theatre. Leveraging EU Cannabis's deep-seated understanding of regional business practices and export regulations, coupled with Kaneh Bosm's expansive distribution network, will allow for continued penetration of the European Union's burgeoning CBD markets and the insatiable appetite for natural medical products."

The alignment of the company's existing distribution channels, revolutionary ADM retail system along with EU Cannabis's robust extraction capabilities will assist in appeasing an expanding appetite for functional CBD products within the European Union.

Under the terms of the agreement, the company will pay $250,000 (U.S.), and it will issue 18 million common shares.

We seek Safe Harbor.